Your browser doesn't support javascript.
loading
The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study.
Stamatopoulos, Basile; Smith, Thomas; Crompot, Emerence; Pieters, Karlien; Clifford, Ruth; Mraz, Marek; Robbe, Pauline; Burns, Adam; Timbs, Adele; Bruce, David; Hillmen, Peter; Meuleman, Nathalie; Mineur, Philippe; Firescu, Radu; Maerevoet, Marie; De Wilde, Virginie; Efira, André; Philippé, Jan; Verhasselt, Bruno; Offner, Fritz; Sims, David; Heger, Andreas; Dreau, Hélène; Schuh, Anna.
Afiliação
  • Stamatopoulos B; Laboratory of Clinical Cell Therapy, Jules Bordet Institute, ULB-Research Cancer Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium. bstamato@ulb.ac.be.
  • Smith T; Molecular Diagnostic Centre, Oxford University Hospitals, Oxford, United Kingdom.
  • Crompot E; Nuffield Department of Laboratory Sciences, University of Oxford, Oxford, United Kingdom.
  • Pieters K; Computational Genomics Analysis and Training Program, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
  • Clifford R; Laboratory of Clinical Cell Therapy, Jules Bordet Institute, ULB-Research Cancer Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Mraz M; Laboratory of Clinical Cell Therapy, Jules Bordet Institute, ULB-Research Cancer Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Robbe P; Molecular Diagnostic Centre, Oxford University Hospitals, Oxford, United Kingdom.
  • Burns A; Nuffield Department of Laboratory Sciences, University of Oxford, Oxford, United Kingdom.
  • Timbs A; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Bruce D; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Hillmen P; Molecular Diagnostic Centre, Oxford University Hospitals, Oxford, United Kingdom.
  • Meuleman N; Nuffield Department of Laboratory Sciences, University of Oxford, Oxford, United Kingdom.
  • Mineur P; Molecular Diagnostic Centre, Oxford University Hospitals, Oxford, United Kingdom.
  • Firescu R; Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Maerevoet M; Molecular Diagnostic Centre, Oxford University Hospitals, Oxford, United Kingdom.
  • De Wilde V; Molecular Diagnostic Centre, Oxford University Hospitals, Oxford, United Kingdom.
  • Efira A; Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Philippé J; St. James' Institute of Oncology, St James' University Hospital, Leeds, United Kingdom.
  • Verhasselt B; Hematology Department, Jules Bordet Institute, Brussels, Belgium.
  • Offner F; Department of Hemato-Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium.
  • Sims D; Hematology Department, CHU Ambroise Paré, Mons, Belgium.
  • Heger A; Hematology Department, Jules Bordet Institute, Brussels, Belgium.
  • Dreau H; Hematology Department, Hôpital Erasme (ULB), Brussels, Belgium.
  • Schuh A; Hematology Department, Hôpital Erasme (ULB), Brussels, Belgium.
Clin Cancer Res ; 24(20): 5048-5057, 2018 10 15.
Article em En | MEDLINE | ID: mdl-29945996

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Região Variável de Imunoglobulina / Leucemia Linfocítica Crônica de Células B / Cadeias Leves de Imunoglobulina Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Cancer Res Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Região Variável de Imunoglobulina / Leucemia Linfocítica Crônica de Células B / Cadeias Leves de Imunoglobulina Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Cancer Res Ano de publicação: 2018 Tipo de documento: Article